RxDoctor Payments Data

Hatice Hasturk

Periodontics · Boston, MANPI 1518284686

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,600 of the $1,694 with a category attached, or 94.4%. GSK accounts for 94.4% of it on its own, with 2 other manufacturers making up the rest.

$1,694in general payments, 2019–2025

Across 4 payments — averaging $423.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • Geistlich Pharma, North America, Inc.$81
  • Zimvie Inc.$13
$787,808in research payments, 2019–2025

Across 9 payments — averaging $87,534 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$358K
  • GSK$224K
  • Sanofi US Services Inc.$205K

What the payments were for

  • Consulting fees$1,60094%
  • Food & beverage$946%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK2$1,600
Geistlich Pharma, North America, Inc.1$81
Zimvie Inc.1$13

How this compares

$1,694 in reported general payments places this provider in the 80th percentile of 243 periodontics providers in Massachusetts.

See all periodontics providers in Massachusetts

Other periodontics in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →